Monument Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.03M | Buy |
2,528
+110
| +5% | +$112K | 0.61% | 59 |
|
|
2026
Q1 | $2.22M | Sell |
2,418
-10
| -0.4% | -$10.1K | 0.56% | 69 |
|
|
2025
Q4 | $2.61M | Buy |
2,428
+12
| +0.5% | +$11.5K | 0.65% | 64 |
|
|
2025
Q3 | $1.84M | Sell |
2,416
-174
| -7% | -$129K | 0.46% | 78 |
|
|
2025
Q2 | $2.02M | Sell |
2,590
-107
| -4% | -$83.1K | 0.53% | 74 |
|
|
2025
Q1 | $2.23M | Sell |
2,697
-21
| -0.8% | -$17.5K | 0.68% | 61 |
|
|
2024
Q4 | $2.1M | Sell |
2,718
-111
| -4% | -$91.9K | 0.58% | 62 |
|
|
2024
Q3 | $2.51M | Sell |
2,829
-13
| -0.5% | -$11.7K | 0.69% | 53 |
|
|
2024
Q2 | $2.57M | Sell |
2,842
-74
| -3% | -$59.2K | 0.76% | 48 |
|
|
2024
Q1 | $2.27M | Buy |
2,916
+38
| +1% | +$27K | 0.65% | 62 |
|
|
2023
Q4 | $1.68M | Buy |
2,878
+78
| +3% | +$45.5K | 0.54% | 62 |
|
|
2023
Q3 | $1.5M | Buy |
2,800
+21
| +0.8% | +$10.8K | 0.5% | 65 |
|
|
2023
Q2 | $1.3M | Buy |
2,779
+165
| +6% | +$69.2K | 0.42% | 68 |
|
|
2023
Q1 | $898K | Sell |
2,614
-228
| -8% | -$76.9K | 0.3% | 75 |
|
|
2022
Q4 | $1.04M | Buy |
2,842
+239
| +9% | +$84.7K | 0.36% | 74 |
|
|
2022
Q3 | $842K | Sell |
2,603
-1,008
| -28% | -$319K | 0.32% | 79 |
|
|
2022
Q2 | $1.17M | Buy |
3,611
+388
| +12% | +$116K | 0.44% | 66 |
|
|
2022
Q1 | $923K | Buy |
3,223
+1,000
| +45% | +$257K | 0.3% | 72 |
|
|
2021
Q4 | $614K | Buy |
2,223
+106
| +5% | +$26.9K | 0.19% | 101 |
|
|
2021
Q3 | $489K | Buy |
2,117
+45
| +2% | +$11.1K | 0.17% | 106 |
|
|
2021
Q2 | $476K | Buy |
2,072
+405
| +24% | +$81.4K | 0.16% | 102 |
|
|
2021
Q1 | $311K | Sell |
1,667
-14,307
| -90% | -$2.8M | 0.12% | 93 |
|
|
2020
Q4 | $2.7M | Buy |
15,974
+610
| +4% | +$91.1K | 1.25% | 25 |
|
|
2020
Q3 | $2.27M | Sell |
15,364
-326
| -2% | -$50.5K | 1.2% | 40 |
|
|
2020
Q2 | $2.58M | Sell |
15,690
-1,003
| -6% | -$154K | 1.52% | 16 |
|
|
2020
Q1 | $2.32M | Buy |
16,693
+158
| +1% | +$21.7K | 1.67% | 18 |
|
|
2019
Q4 | $2.17M | Buy |
16,535
+75
| +0.5% | +$8.69K | 1.11% | 45 |
|
|
2019
Q3 | $1.84M | Sell |
16,460
-480
| -3% | -$53.4K | 1% | 49 |
|
|
2019
Q2 | $1.91M | Sell |
16,940
-346
| -2% | -$40.7K | 1.03% | 48 |
|
|
2019
Q1 | $2.24M | Sell |
17,286
-807
| -4% | -$98.1K | 1.28% | 33 |
|
|
2018
Q4 | $2.09M | Buy |
18,093
+17,380
| +2,438% | +$1.94M | 1.31% | 31 |
|
|
2018
Q3 | $77K | Buy |
713
+200
| +39% | +$20K | 0.04% | 113 |
|
|
2018
Q2 | $44K | Hold |
513
| – | – | 0.03% | 98 |
|
|
2018
Q1 | $38K | Hold |
513
| – | – | 0.03% | 97 |
|
|
2017
Q4 | $43K | Buy |
+513
| New | +$43.6K | 0.03% | 87 |
|
Other funds holding LLY
SC
Monument Capital Management's LLY Position: Q2 2026 in Review
Monument Capital Management increased its Eli Lilly (LLY) stake by 4.5% in Q2 2026, buying an estimated $112K and bringing the position to 2,528 shares worth $3.03M. The position accounts for 0.61% of the portfolio, ranked #59.
Monument Capital Management first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 2,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Monument Capital Management held 2,528 shares of Eli Lilly worth $3.03M as of Q2 2026.
- Monument Capital Management bought 110 Eli Lilly shares in Q2 2026, an estimated $112K.
- Eli Lilly made up 0.61% of Monument Capital Management's portfolio in Q2 2026, its #59 holding.
- Monument Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
- 2,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.